SARS‐CoV‐2 pseudovirus infectivity and expression of viral entry‐related factors ACE2, TMPRSS2, Kim‐1, and NRP‐1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems
Open Access
- 4 August 2021
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (12) , 6671-6685
Abstract
Infection by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causes a wide spectrum of syndromes involving multiple organ systems and is primarily mediated by viral spike (S) glycoprotein through the receptor‐binding domain (RBD) and numerous cellular proteins including ACE2, transmembrane serine protease 2 (TMPRSS2), kidney injury molecule‐1 (Kim‐1), and neuropilin‐1 (NRP‐1). In this study, we examined the entry tropism of SARS‐CoV‐2 and SARS‐CoV using S protein‐based pseudoviruses to infect 22 cell lines and 3 types of primary cells isolated from respiratory, urinary, digestive, reproductive, and immune systems. At least one cell line or type of primary cell from each organ system was infected by both pseudoviruses. Infection by pseudoviruses is effectively blocked by S1, RBD, and ACE2 recombinant proteins, and more weakly by Kim‐1 and NRP‐1 recombinant proteins. Furthermore, cells with robust SARS‐CoV‐2 pseudovirus infection had strong expression of either ACE2 or Kim‐1 and NRP‐1 proteins. ACE2 glycosylation appeared to be critical for the infections of both viruses as there was a positive correlation between infectivity of either SARS‐CoV‐2 or SARS‐CoV pseudovirus with the level of glycosylated ACE2 (gly‐ACE2). These results reveal that SARS‐CoV‐2 cell entry could be mediated by either an ACE2‐dependent or ‐independent mechanism, thus providing a likely molecular basis for its broad tropism for a wide variety of cell types.Keywords
This publication has 50 references indexed in Scilit:
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measuresJournal of Medical Virology, 2020
- Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patientbioRxiv, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike ProteinJournal of Virology, 2014
- Ectodomain shedding of angiotensin converting enzyme 2 in human airway epitheliaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- SARS: clinical virology and pathogenesisRespirology, 2003
- Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injuryKidney International, 2002